A detailed history of Mont Vue Capital Management, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Mont Vue Capital Management, Inc. holds 2,089 shares of NVO stock, worth $252,267. This represents 0.24% of its overall portfolio holdings.

Number of Shares
2,089
Previous 1,610 29.75%
Holding current value
$252,267
Previous $207 Million 44.24%
% of portfolio
0.24%
Previous 0.18%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$122.71 - $146.91 $58,778 - $70,369
479 Added 29.75%
2,089 $298 Million
Q1 2024

May 03, 2024

BUY
$102.11 - $135.92 $164,397 - $218,831
1,610 New
1,610 $207 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $273B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Mont Vue Capital Management, Inc. Portfolio

Follow Mont Vue Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mont Vue Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mont Vue Capital Management, Inc. with notifications on news.